Phase 3 Trial of Semaglutide in Metabolic DysfunctionAssociated Steatohepatitis, New England Journal of Medicine Consistent with previous trials, the semaglutide group also lost more body weight and had significant improvements in blood pressure, blood glucose, lipids, and inflammation compared to the placebo group
Neelam, Khatkar A, Sharma KK
Interestingly, the generation of R-2-HG from glutamine has been proven to occur rapidly in patient-derived chondrosarcoma cell lines harboring endogenous IDH mutations, indicating fundamental metabolic differences between cells that harbor IDH1/2 mutations and those that do not 121
Ipamorelin 3mg Turkey Research has demonstrated that Ipamorelin is a powerful growth hormone secretagogue that stimulates natural growth hormone release without disrupting other hormones
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes (Rosenstock et al.)